How our technology helps you know what, faster
EpiSLS is a medical device which offers the first option for point of care allergy testing in every care setting. Our system was designed to be accessible, affordable, and safe for any patient who is eligible to receive traditional in-office testing.
EpiSLS comprises two interlocking components: a reusable technology unit containing the sensing hardware and a replaceable, single use applicator unit acting as a reservoir and delivery tool for panels of allergens.
The epiSLS system utilizes an optical sensor that detects hypersensitivity reactions based on low energy light allowing it to bring this specialized care to patients no matter where they are or when they need it. This new method of measuring and characterizing immune cell activity directly in the skin allows the device to determine risk of systemic allergic reaction faster and more accurately than traditional methods.
EpiSLS reconciles millions of datapoints to create a detailed reconstruction and quantifiable measure of what is happening inside a patient’s body. Here we see a visualized representation of two patient’s skin each showing the development of wheals meaning the patient is allergic.
Versatile applications across all type 1 allergies
Value creation for all stakeholders
Ability to screen allergies
Can use effective, less costly drugs
Reduced readmissions, costs, and complications
Access to allergy testing
Better healthcare outcomes